• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prostate cancer screening with prostate-specific antigen: Where are we going?

作者信息

Albertsen Peter C

机构信息

Department of Surgery (Urology), University of Connecticut Health Center, Farmington, Connecticut.

出版信息

Cancer. 2018 Feb 1;124(3):453-455. doi: 10.1002/cncr.31140. Epub 2017 Dec 12.

DOI:10.1002/cncr.31140
PMID:29231972
Abstract
摘要

相似文献

1
Prostate cancer screening with prostate-specific antigen: Where are we going?使用前列腺特异性抗原进行前列腺癌筛查：我们何去何从？
Cancer. 2018 Feb 1;124(3):453-455. doi: 10.1002/cncr.31140. Epub 2017 Dec 12.
2
Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm.数字直肠检查和前列腺特异性抗原在前列腺、肺、结直肠和卵巢（PLCO）癌症筛查中的预后意义。
J Urol. 2017 Feb;197(2):363-368. doi: 10.1016/j.juro.2016.08.092. Epub 2016 Aug 26.
3
Trade-Off between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era.前列腺癌筛查时代早期前列腺癌治疗与晚期前列腺癌发病风险的权衡。
J Urol. 2016 May;195(5):1397-1402. doi: 10.1016/j.juro.2015.11.056. Epub 2015 Dec 2.
4
Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.初级保健医生中前列腺癌筛查的下降：数字直肠检查和前列腺特异性抗原检测使用趋势分析。
J Urol. 2016 Oct;196(4):1047-52. doi: 10.1016/j.juro.2016.03.171. Epub 2016 Apr 6.
5
Prostate specific antigen - useful screening tool or potential liability?前列腺特异性抗原——有用的筛查工具还是潜在的负担？
Aust Fam Physician. 2010 Aug;39(8):598-600.
6
Clinical characteristics and prostate-specific antigen kinetics of prostate cancer detected in repeat annual population screening in Japan.日本年度重复人群筛查中检测出的前列腺癌的临床特征及前列腺特异性抗原动力学
Int J Urol. 2014 May;21(5):461-5. doi: 10.1111/iju.12304. Epub 2013 Oct 17.
7
Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen Screening.中期前列腺癌风险与基线前列腺特异性抗原直接相关：减少前列腺特异性抗原筛查负担的意义。
J Urol. 2015 Jul;194(1):46-51. doi: 10.1016/j.juro.2015.02.043. Epub 2015 Feb 14.
8
Trends in Prostate-Specific Antigen Screening and Prostate Cancer Interventions 3 Years After the U.S. Preventive Services Task Force Recommendation.美国预防服务工作组发布建议三年后前列腺特异性抗原筛查及前列腺癌干预措施的趋势
Ann Intern Med. 2017 Mar 21;166(6):451-452. doi: 10.7326/L16-0422.
9
Estimate of Opportunistic Prostate Specific Antigen Testing in the Finnish Randomized Study of Screening for Prostate Cancer.芬兰前列腺癌筛查随机研究中机会性前列腺特异性抗原检测的评估。
J Urol. 2017 Jul;198(1):50-57. doi: 10.1016/j.juro.2017.01.048. Epub 2017 Jan 16.
10
Improving Prostate Cancer Screening and Diagnosis: Health Policy and Biomarkers Beyond PSA.改善前列腺癌筛查与诊断：超越前列腺特异性抗原的卫生政策与生物标志物
JAMA Oncol. 2016 Jul 1;2(7):867-8. doi: 10.1001/jamaoncol.2016.0170.

引用本文的文献

1
Use of a BMI-independent biomarker-based prostate cancer risk score to identify and triage individuals at risk of prostate disease.使用基于生物标志物的前列腺癌风险评分（与体重指数无关）来识别和分类有前列腺疾病风险的个体。
Sci Rep. 2025 Jul 24;15(1):26864. doi: 10.1038/s41598-025-13036-w.
2
Nomograms Combining PHI and PI-RADS in Detecting Prostate Cancer: A Multicenter Prospective Study.结合前列腺健康指数（PHI）和前列腺影像报告和数据系统（PI-RADS）检测前列腺癌的列线图：一项多中心前瞻性研究。
J Clin Med. 2023 Jan 1;12(1):339. doi: 10.3390/jcm12010339.
3
Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0-25.0 ng ml in Western China.
在中国西部，总 PSA 水平在 2.0-25.0ng/ml 之间的 50 岁以上男性，游离/总 PSA 比值在前列腺癌诊断中的临床应用。
Asian J Androl. 2022 Mar-Apr;24(2):195-200. doi: 10.4103/aja202182.
4
Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer.巨噬细胞凋亡抑制因子（AIM）水平高与前列腺特异性抗原（PSA）水平低同时出现表明活化的T细胞介导的抗癌免疫，增强对帕博利珠单抗的敏感性，并预示前列腺癌预后良好。
Biomedicines. 2021 Sep 15;9(9):1225. doi: 10.3390/biomedicines9091225.
5
ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.ALG3 通过调节乳腺癌中 TGF-β 受体 II 的糖基化作用来促进干性和放射抗性。
J Exp Clin Cancer Res. 2021 Apr 30;40(1):149. doi: 10.1186/s13046-021-01932-8.
6
Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein.鉴定一种新的非侵入性生物标志物，以克服 PSA 在前列腺癌诊断和风险分层中的不足：发育内皮定位 1 蛋白的初步前瞻性研究。
PLoS One. 2021 Apr 26;16(4):e0250254. doi: 10.1371/journal.pone.0250254. eCollection 2021.
7
White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft.白蘑菇（双孢蘑菇）可破坏人前列腺癌细胞和患者来源异种移植模型中的雄激素受体信号。
J Nutr Biochem. 2021 Mar;89:108580. doi: 10.1016/j.jnutbio.2020.108580. Epub 2020 Dec 31.
8
Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer.糖基化在癌症中转化生长因子-β信号传导及上皮-间质转化中的作用
Protein Cell. 2021 Feb;12(2):89-106. doi: 10.1007/s13238-020-00741-7. Epub 2020 Jun 25.